{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:08:35Z","timestamp":1789070915656,"version":"build-2803163510"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119069","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:27:47Z","timestamp":1781537267000},"page":"119069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hydroxycoumarins and coumarin-based derivatives as kinase-targeted anticancer agents: Chemistry, structure\u2013activity relationships, and mechanistic insights"],"prefix":"10.1016","volume":"317","author":[{"given":"Asif Ahmad","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivkanya","family":"Fuloria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Narain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushboo","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangita","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumita","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj Kumar","family":"Fuloria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejmech.2026.119069_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"24","key":"10.1016\/j.ejmech.2026.119069_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417600","article-title":"An update on protein kinases as therapeutic targets-part I: protein kinase C activation and its role in cancer and cardiovascular diseases","volume":"24","author":"Silnitsky","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119069_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107059","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2024 update","volume":"200","author":"Roskoski","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12943-025-02353-3","article-title":"Aurora kinases signaling in cancer: from molecular perception to targeted therapies","volume":"24","author":"Vats","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1039\/D3MD00511A","article-title":"Latest developments in coumarin-based anticancer agents: mechanism of action and structure-activity relationship studies","volume":"15","author":"Koley","year":"2024","journal-title":"RSC Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2026.119069_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30214167","article-title":"Coumarin derivatives as anticancer agents: mechanistic landscape with an emphasis on breast cancer","volume":"30","author":"Hacholli","year":"2025","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13065-018-0497-z","article-title":"Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A\/B and \u03b2-amyloid inhibitors for Alzheimer's disease","volume":"12","author":"Yusufzai","year":"2018","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.ejmech.2026.119069_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmcr.2022.100038","article-title":"Recent advances on anticancer activity of coumarin derivatives","volume":"5","author":"Rawat","year":"2022","journal-title":"European Journal of Medicinal Chemistry Reports"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119069_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115328","article-title":"VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents","volume":"28","author":"Ahmed","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119069_bib10","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1039\/D3MD00668A","article-title":"Coumarin\u2013furo [2, 3-d] pyrimidone hybrid molecules targeting human liver cancer cells: synthesis, anticancer effect, EGFR inhibition and molecular docking studies","volume":"15","author":"Wang","year":"2024","journal-title":"RSC Med. Chem."},{"issue":"27","key":"10.1016\/j.ejmech.2026.119069_bib11","doi-asserted-by":"crossref","first-page":"18838","DOI":"10.1039\/D4RA02456G","article-title":"Design, synthesis, and anticancer evaluation of novel coumarin\/thiazole congeners as potential CDK2 inhibitors with molecular dynamics","volume":"14","author":"Bondock","year":"2024","journal-title":"RSC Adv."},{"issue":"34","key":"10.1016\/j.ejmech.2026.119069_bib12","doi-asserted-by":"crossref","first-page":"24671","DOI":"10.1039\/D4RA04226C","article-title":"Coumarin-amino acid hybrids as promising anticancer agents: design, synthesis, docking studies and CK2 inhibition","volume":"14","author":"El-Etrawy","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119069_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107682","article-title":"Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET\/STAT-3 inhibitors for potential antitumor agents","volume":"151","author":"Naguib","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119069_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130240","article-title":"Design, synthesis and biological evaluation of coumarin-containing 2,4-diphenylpyrimidine derivatives as novel focal adhesion kinase inhibitors for treatment of non-small cell lung cancer","volume":"123","author":"Lei","year":"2025","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"39","key":"10.1016\/j.ejmech.2026.119069_bib15","doi-asserted-by":"crossref","first-page":"32821","DOI":"10.1039\/D5RA04395F","article-title":"Design, synthesis and molecular modeling of new coumarin-thiazole derivatives as dual EGFR\/HDAC1 inhibitors: in vitro and in vivo anticancer assays","volume":"15","author":"Ahmed","year":"2025","journal-title":"RSC Adv."},{"issue":"42","key":"10.1016\/j.ejmech.2026.119069_bib16","doi-asserted-by":"crossref","first-page":"29070","DOI":"10.1039\/D3RA03483F","article-title":"EGFR and PI3K\/m-TOR inhibitors: design, microwave assisted synthesis and anticancer activity of thiazole-coumarin hybrids","volume":"13","author":"Batran","year":"2023","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2311157","article-title":"Development of certain benzylidene coumarin derivatives as anti-prostate cancer agents targeting EGFR and PI3K\u03b2 kinases","volume":"39","author":"Abdel Ghany","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119069_bib18","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1039\/D4RA00157E","article-title":"New pyrazolylindolin-2-one based coumarin derivatives as anti-melanoma agents: design, synthesis, dual BRAF(V600E)\/VEGFR-2 inhibition, and computational studies","volume":"14","author":"Sabt","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119069_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137790","article-title":"Anticancer activity of new triazolopyrimidine linked coumarin and quinolone hybrids: synthesis, molecular modeling, TrkA, PI3K\/AKT and EGFR inhibition","volume":"1305","author":"Batran","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119069_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139123","article-title":"Design, synthesis and molecular modeling of pyrazoline based coumarin derivatives as tubulin polymerization inhibitors","volume":"1318","author":"Batran","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119069_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130444","article-title":"Coumarin\u2013benzimidazole hybrids: design, synthesis and identification of potential anticancer agents","volume":"131","author":"Arya","year":"2026","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119069_bib22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1006\/bbrc.1999.0958","article-title":"Daphnetin, one of coumarin derivatives, is a protein kinase inhibitor","volume":"260","author":"Yang","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.119069_bib23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bioorg.2016.06.005","article-title":"3-Substituted-4-hydroxycoumarin as a new scaffold with potent CDK inhibition and promising anticancer effect: synthesis, molecular modeling and QSAR studies","volume":"67","author":"Abdel Latif","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119069_bib24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ejmech.2018.01.024","article-title":"Discovery of novel HSP90 inhibitors that induced apoptosis and impaired autophagic flux in A549 lung cancer cells","volume":"145","author":"Wei","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119069_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bioorg.2019.01.026","article-title":"New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: synthesis, CDK2 inhibition, QSAR and molecular docking studies","volume":"86","author":"Abd El-Karim","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40232-3","article-title":"Developing multitarget coumarin based anti-breast cancer agents: synthesis and molecular modeling study","volume":"13","author":"Takla","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119069_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153465","article-title":"Daphnetin triggers ROS-induced cell death and induces cytoprotective autophagy by modulating the AMPK\/Akt\/mTOR pathway in ovarian cancer","volume":"82","author":"Fan","year":"2021","journal-title":"Phytomedicine"},{"issue":"50","key":"10.1016\/j.ejmech.2026.119069_bib28","doi-asserted-by":"crossref","first-page":"61899","DOI":"10.1021\/acsomega.5c08635","article-title":"Coumarin-1,2,3-Triazole conjugates as molecular scaffolds for the selective induction of ROS-driven apoptosis in cancer cells in the development of pyruvate kinase M2 inhibitors","volume":"10","author":"Ouverney","year":"2025","journal-title":"ACS Omega"},{"issue":"24","key":"10.1016\/j.ejmech.2026.119069_bib29","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1021\/jm0707774","article-title":"New novobiocin analogues as antiproliferative agents in breast cancer cells and potential inhibitors of heat shock protein 90","volume":"50","author":"Le Bras","year":"2007","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2008.09.001","article-title":"Antiproliferative and apoptotic activities of tosylcyclonovobiocic acids as potent heat shock protein 90 inhibitors in human cancer cells","volume":"274","author":"Radanyi","year":"2009","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119069_bib31","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1021\/jf100352c","article-title":"Osthole suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt\/mTOR pathway","volume":"58","author":"Lin","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2026.119069_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bioorg.2018.12.040","article-title":"Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis","volume":"85","author":"Mohamed","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119069_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128258","article-title":"Angiokinase inhibition of VEGFR-2, PDGFR and FGFR and cell growth inhibition in lung cancer: design, synthesis, biological evaluation and molecular docking of novel azaheterocyclic coumarin derivatives","volume":"48","author":"Ahmed","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"23","key":"10.1016\/j.ejmech.2026.119069_bib34","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.3390\/molecules27238279","article-title":"Facile synthesis of some coumarin derivatives and their cytotoxicity through VEGFR2 and topoisomerase II inhibition","volume":"27","author":"Gomaa","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119069_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28020689","article-title":"Synthesis and molecular docking of some novel 3-Thiazolyl-Coumarins as inhibitors of VEGFR-2 kinase","volume":"28","author":"Abolibda","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119069_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101819","article-title":"Synthesis, biological evaluation, and in silico study of novel coumarin-quinazoline analogs as potential anti-angiogenesis agents","volume":"11","author":"Emamgholipour","year":"2024","journal-title":"Results Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119069_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400297","article-title":"Exploring novel coumarin-tethered Bis-Triazoles: Apoptosis induction in human pancreatic cancer cells, antimicrobial effects, and molecular modelling investigations","volume":"19","author":"Dhawan","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119069_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202400435","article-title":"Design and synthesis of potent anticancer agents using coumarin\u2010quinazolinone based scaffolds: exploration of ADME properties and molecular docking studies","volume":"9","author":"Babagond","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2026.119069_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2025.109620","article-title":"Design, synthesis, and in-silico studies of hydrazide-hydrazone linked coumarin glycoconjugates with possible antiproliferative activity","volume":"556","author":"Kumar","year":"2025","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2026.119069_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cbi.2014.04.015","article-title":"Induction of ROS-independent JNK-activation-mediated apoptosis by a novel coumarin-derivative, DMAC, in human colon cancer cells","volume":"218","author":"Lin","year":"2014","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119069_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/CAD.0000000000000232","article-title":"Derivatives containing both coumarin and benzimidazole potently induce caspase-dependent apoptosis of cancer cells through inhibition of PI3K-AKT-mTOR signaling","volume":"26","author":"Liu","year":"2015","journal-title":"Anti Cancer Drugs"},{"issue":"19","key":"10.1016\/j.ejmech.2026.119069_bib42","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.3390\/molecules27196709","article-title":"Design and synthesis of coumarin derivatives as cytotoxic agents through PI3K\/AKT signaling pathway inhibition in HL60 and HepG2 cancer cells","volume":"27","author":"Kishk","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib43","first-page":"85","article-title":"Antiproliferative activity of an angular furanocoumarin-oroselol in human oral cancer cells is mediated via autophagy induction, inhibition of cell migration, invasion, and downregulation of PI3K\/AKT signalling pathway","volume":"69","author":"Wang","year":"2022","journal-title":"Acta Biochim. Pol."},{"issue":"13","key":"10.1016\/j.ejmech.2026.119069_bib44","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.3390\/molecules28135226","article-title":"A coumarin\u2013imidazothiadiazole derivative, SP11 abrogates tumor growth by targeting HSP90 and its client proteins","volume":"28","author":"Nirgude","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-81911-z","article-title":"Osthole induces accumulation of impaired autophagosome against pancreatic cancer cells","volume":"14","author":"Weng","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119069_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107116","article-title":"Four undescribed coumarin derivatives, with ten amides from the roots of Ficus hirta and their cytotoxic activities","volume":"144","author":"Ye","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119069_bib47","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/antiox13060669","article-title":"Osthole suppresses cell growth of prostate cancer by disrupting redox homeostasis, mitochondrial function, and regulation of tiRNAHisGTG","volume":"13","author":"Song","year":"2024","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejmech.2009.10.011","article-title":"Docking and 3D-QSAR studies of 7-hydroxycoumarin derivatives as CK2 inhibitors","volume":"45","author":"Zhang","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10637-009-9335-4","article-title":"A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells","volume":"29","author":"Singh","year":"2011","journal-title":"Invest. N. Drugs"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119069_bib50","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1021\/tx400271n","article-title":"N-Hydroxycinnamide derivatives of osthole presenting genotoxicity and cytotoxicity against human Colon adenocarcinoma cells in vitro and in vivo","volume":"26","author":"Liu","year":"2013","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/minf.201500091","article-title":"Rational design of coumarin derivatives as CK2 inhibitors by improving the interaction with the Hinge Region","volume":"35","author":"Zhang","year":"2016","journal-title":"Mol. Inf."},{"key":"10.1016\/j.ejmech.2026.119069_bib52","article-title":"MCR-click synthesis, molecular docking and cytotoxicity evaluation of a new series of indole-triazole-coumarin hybrid peptidomimetics","volume":"42","author":"Bahulayan","year":"2018","journal-title":"New J. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2026.119069_bib53","doi-asserted-by":"crossref","first-page":"14010","DOI":"10.1039\/D6RA00253F","article-title":"Development, anti-proliferative activity, multi-target kinase inhibition against CHK1, PIM1, and CDK-2, and computational insights of new thiazole-based hybrids","volume":"16","author":"Altwaijry","year":"2026","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119069_bib54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bioorg.2018.12.040","article-title":"Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis","volume":"85","author":"Mohamed","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119069_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128258","article-title":"Angiokinase inhibition of VEGFR-2, PDGFR and FGFR and cell growth inhibition in lung cancer: design, synthesis, biological evaluation and molecular docking of novel azaheterocyclic coumarin derivatives","volume":"48","author":"Ahmed","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119069_bib56","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cbi.2014.04.015","article-title":"Induction of ROS-independent JNK-activation-mediated apoptosis by a novel coumarin-derivative, DMAC, in human colon cancer cells","volume":"218","author":"Lin","year":"2014","journal-title":"Chem. Biol. Interact."},{"issue":"19","key":"10.1016\/j.ejmech.2026.119069_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27196709","article-title":"Design and synthesis of coumarin derivatives as cytotoxic agents through PI3K\/AKT signaling pathway inhibition in HL60 and HepG2 cancer cells","volume":"27","author":"Kishk","year":"2022","journal-title":"Molecules"},{"issue":"13","key":"10.1016\/j.ejmech.2026.119069_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28135226","article-title":"A coumarin-imidazothiadiazole derivative, SP11 abrogates tumor growth by targeting HSP90 and its client proteins","volume":"28","author":"Nirgude","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119069_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13060669","article-title":"Osthole suppresses cell growth of prostate cancer by disrupting redox homeostasis, mitochondrial function, and regulation of tiRNA(HisGTG)","volume":"13","author":"Song","year":"2024","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10637-009-9335-4","article-title":"A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells","volume":"29","author":"Singh","year":"2011","journal-title":"Invest. N. Drugs"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119069_bib61","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1021\/tx400271n","article-title":"N-Hydroxycinnamide derivatives of osthole presenting genotoxicity and cytotoxicity against human colon adenocarcinoma cells in vitro and in vivo","volume":"26","author":"Liu","year":"2013","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/minf.201500091","article-title":"Rational design of coumarin derivatives as CK2 inhibitors by improving the interaction with the Hinge Region","volume":"35","author":"Zhang","year":"2016","journal-title":"Mol. Inf."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119069_bib63","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/vetsci10020084","article-title":"Antitumor effects of esculetin, a natural coumarin derivative, against canine mammary gland tumor cells by inducing cell cycle arrest and apoptosis","volume":"10","author":"Choi","year":"2023","journal-title":"Vet. Sci."},{"key":"10.1016\/j.ejmech.2026.119069_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2024.112142","article-title":"Synthesis, characterization, and anticancer potency of coumarin-derived thiosemicarbazones and their Copper(II) complexes","volume":"161","author":"Shrestha","year":"2024","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.ejmech.2026.119069_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118118","article-title":"Esculetin inhibits liver cancer by targeting glucose-6-phosphate isomerase mediated glycolysis","volume":"188","author":"Hong","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib66","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s44371-025-00369-8","article-title":"Design, synthesis, biological evaluation and in-silico study of thioether-linked 4-hydroxycoumarin-benzothiazole derivatives targeting EGFR for cancer therapy","volume":"2","author":"Bora","year":"2025","journal-title":"Discover Chemistry"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-26301-9","article-title":"Synthesis, biological evaluation, and molecular docking of novel coumarin-based bisimine derivatives","volume":"15","author":"Abazari","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119069_bib68","first-page":"1","article-title":"Multitarget evaluation of 4-substituted 7-hydroxycoumarin derivatives: anticancer activity, topoisomerase I inhibition, and interaction with human serum albumin","author":"Guck\u00fd","year":"2026","journal-title":"N. Schmied. Arch. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119069_bib69","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jscs.2019.12.001","article-title":"Uracil-coumarin based hybrid molecules as potent anti-cancer and anti-bacterial agents","volume":"24","author":"Sanduja","year":"2020","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119069_bib70","first-page":"1","volume":"10","author":"Mohit Sanduja","year":"2020"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119069_bib71","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.3390\/molecules28083450","article-title":"Discovery of Pyrimidine- and coumarin-linked hybrid molecules as inducers of JNK phosphorylation through ROS generation in breast cancer cells","volume":"28","author":"Kim","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119069_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.145188","article-title":"Novel pyrazole-coumarin-linked 1,2,3-triazole conjugates: synthesis, biological evaluation and molecular docking study","volume":"1357","author":"Bhalmode","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119069_bib73","article-title":"Novel pyrazole-coumarin-linked 1,2,3-triazole conjugates: synthesis, biological evaluation and molecular docking study","volume":"1357","author":"Bhalmode","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119069_bib89","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bioorg.2016.06.005","article-title":"3-Substituted-4-hydroxycoumarin as a new scaffold with potent CDK inhibition and promising anticancer effect: synthesis, molecular modeling and QSAR studies","volume":"67","author":"Abdel Latif","year":"2016","journal-title":"Bioorg. Chem."},{"issue":"27","key":"10.1016\/j.ejmech.2026.119069_bib74","doi-asserted-by":"crossref","first-page":"18838","DOI":"10.1039\/D4RA02456G","article-title":"Design, synthesis, and anticancer evaluation of novel coumarin\/thiazole congeners as potential CDK2 inhibitors with molecular dynamics\u2020\u2020electronic supplementary information (ESI) available. See","volume":"14","author":"Bondock","year":"2024","journal-title":"RSC Adv."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119069_bib75","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1039\/D3MD00668A","article-title":"Coumarin-furo[2,3-d]pyrimidone hybrid molecules targeting human liver cancer cells: synthesis, anticancer effect, EGFR inhibition and molecular docking studies","volume":"15","author":"Wang","year":"2024","journal-title":"RSC Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119069_bib76","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1021\/jm901453q","article-title":"Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer","volume":"53","author":"Cai","year":"2010","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119069_bib77","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3390\/ph14090869","article-title":"New incretin combination treatments under investigation in obesity and metabolism: a systematic review","volume":"14","author":"Kakouri","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.119069_bib78","article-title":"Target-specific compound selectivity for multi-target drug discovery and repurposing","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib79","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1038\/s41598-020-59074-4","article-title":"The kinase polypharmacology landscape of clinical PARP inhibitors","volume":"10","author":"Antolin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119069_bib80","article-title":"Characterization of a chromen-based anticancer agent using computer-aided drug discovery reveals selective interaction with EGFR and VEGFR2","volume":"1","author":"Tuah","year":"2025"},{"issue":"12","key":"10.1016\/j.ejmech.2026.119069_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ph18121899","article-title":"Evaluation of antiproliferative activity and molecular modeling studies of some novel benzimidazolone-bridged hybrid compounds","volume":"18","author":"G\u00fcven","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.ejmech.2026.119069_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202501775","article-title":"Design, synthesis, and molecular docking of triazole-coumarin hybrids as potent breast cancer inhibitors targeting cell cycle and apoptosis","volume":"22","author":"Keser","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2026.119069_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118535","article-title":"New pyrazolo[1,5-a]pyrimidine derivatives as potential CDK2 inhibitors and apoptosis-driven antiproliferative agents","volume":"134","author":"El-Rahmany","year":"2026","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119069_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2024.106105","article-title":"Novel coumarin-piperazine-2(5H)-furanone hybrids as potential anti-lung cancer agents: synthesis, biological evaluation and molecular docking studies","volume":"177","author":"Zhang","year":"2024","journal-title":"Fitoterapia"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib85","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/19336918.2024.2418049","article-title":"Inhibition of JNK\/STAT3\/NF-KB pathway-mediated migration and clonal formation of lung adenocarcinoma A549 cells by daphnetin","volume":"18","author":"Lv","year":"2024","journal-title":"Cell Adhes. Migrat."},{"key":"10.1016\/j.ejmech.2026.119069_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130240","article-title":"Design, synthesis and biological evaluation of coumarin-containing 2,4-diphenylpyrimidine derivatives as novel focal adhesion kinase inhibitors for treatment of non-small cell lung cancer","volume":"123","author":"Lei","year":"2025","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119069_bib87","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/0109298673298471240605072658","article-title":"Determination of inhibitory effect of PKM2 enzyme and antitumoral activity of novel coumarin-naphthoquinone hybrids","volume":"32","author":"de Andrade Borges","year":"2025","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib88","article-title":"Development of certain benzylidene coumarin derivatives as anti-prostate cancer agents targeting EGFR and PI3K\u03b2 kinases","volume":"39","author":"Elagawany","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119069_bib90","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2174\/0118715206340868241018075528","article-title":"In vivo, in vitro, and in silico studies of umbelliferone and irinotecan on MDA-MB-231 breast cancer cell line and Drosophila melanogaster larvae","volume":"25","author":"Tamturk","year":"2025","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119069_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.70128","article-title":"Determination of the in vitro cytotoxic activities of several coumarin derivatives on neuroblastoma cell lines with in silico inhibitory effects on CDK9, VEGFR2 and EGFR proteins and ADME studies","volume":"43","author":"Celikezen","year":"2025","journal-title":"Cell Biochem. Funct."},{"issue":"null","key":"10.1016\/j.ejmech.2026.119069_bib92","article-title":"Evaluation of new coumarins for anti-cancer activity in HL-60 cell line supported by molecular docking, MD simulation, and binding free energy calculations","volume":"19","author":"Humayun","year":"2026","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib93","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119069_bib94","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119069_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119069_bib96","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"issue":"W1","key":"10.1016\/j.ejmech.2026.119069_bib97","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.ejmech.2026.119069_bib98","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:02:27Z","timestamp":1787040147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":98,"alternative-id":["S0223523426005143"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119069","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxycoumarins and coumarin-based derivatives as kinase-targeted anticancer agents: Chemistry, structure\u2013activity relationships, and mechanistic insights","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119069"}}